Literature DB >> 17964552

Kainate receptors are primarily postsynaptic to SP-containing axon terminals in the trigeminal dorsal horn.

Deborah M Hegarty1, Jennifer L Mitchell, Kristin C Swanson, Sue A Aicher.   

Abstract

Kainate receptors (KARs) are involved in the modulation and transmission of nociceptive information from peripheral afferents to neurons in the spinal cord and trigeminal dorsal horns. KARs are found at both pre- and postsynaptic sites in the dorsal horn. We hypothesized that KARs and Substance P (SP), a modulatory neuropeptide that is used as a marker of nociceptive afferents, have a complex interactive relationship. To determine the cellular relationship and connectivity between KARs and SP afferents, we used electron microscopic dual immunocytochemical analysis to examine the ultrastructural localization of KAR subunits GluR5, 6 and 7 (GluR5,6,7) in relation to SP within laminae I and II in the rat trigeminal dorsal horn. KARs were distributed both postsynaptically in dendrites and somata (51% of GluR5,6,7 immunoreactive (-ir) profiles) and presynaptically in axons and axon terminals (45%). We also found GluR5,6,7-ir glial profiles (5%). The majority of SP-ir profiles were presynaptic axons and axon terminals. SP-ir dendritic profiles were rare, yet 23% contained GluR5,6,7 immunoreactivity. GluR5,6,7 and SP were also colocalized at presynaptic sites (18% of GluR5,6,7-ir axons and axon terminals contained SP; while 11% of SP-ir axons and axon terminals contained GluR5,6,7). The most common interaction between KARs and SP we observed was GluR5,6,7-ir dendrites contacted by SP-ir axon terminals; 54% of the dendritic targets of SP-ir axon terminals were GluR5,6,7-ir. These results provide anatomical evidence that KARs primarily mediate nociceptive transmission postsynaptic to SP-containing afferents and may also modulate the presynaptic release of SP and glutamate in trigeminal dorsal horn.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964552      PMCID: PMC2238683          DOI: 10.1016/j.brainres.2007.09.070

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  73 in total

1.  Abnormal substance P release from the spinal cord following injury to primary sensory neurons.

Authors:  M Malcangio; M S Ramer; M G Jones; S B McMahon
Journal:  Eur J Neurosci       Date:  2000-01       Impact factor: 3.386

Review 2.  Subcellular localization and trafficking of kainate receptors.

Authors:  Frédéric Jaskolski; Françoise Coussen; Christophe Mulle
Journal:  Trends Pharmacol Sci       Date:  2005-01       Impact factor: 14.819

3.  Presynaptic low- and high-affinity kainate receptors in nociceptive spinal afferents.

Authors:  Simona Lucifora; Helen H Willcockson; Chun-Rong Lu; Melanie Darstein; Kris D Phend; Juli G Valtschanoff; Aldo Rustioni
Journal:  Pain       Date:  2005-12-15       Impact factor: 6.961

Review 4.  Kainate receptors.

Authors:  Paulo Pinheiro; Christophe Mulle
Journal:  Cell Tissue Res       Date:  2006-07-18       Impact factor: 5.249

Review 5.  Spinal and trigeminal mechanisms of nociception.

Authors:  R Dubner; G J Bennett
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

6.  The spinal antinociceptive effects of a novel competitive AMPA receptor antagonist, YM872, on thermal or formalin-induced pain in rats.

Authors:  T Nishiyama; L Gyermek; C Lee; S Kawasaki-Yatsugi; T Yamaguchi
Journal:  Anesth Analg       Date:  1999-07       Impact factor: 5.108

7.  Alterations in neurokinin A-, substance P- and calcitonin gene-related peptide immunoreactivities in the caudal trigeminal nucleus of the rat following electrical stimulation of the trigeminal ganglion.

Authors:  M Samsam; R Coveñas; R Ahangari; J Yajeya; J A Narváez; G Tramu
Journal:  Neurosci Lett       Date:  1999-02-19       Impact factor: 3.046

8.  Redistribution of mu-opioid receptors in C1 adrenergic neurons following chronic administration of morphine.

Authors:  Carrie T Drake; Sue A Aicher; Fritzline L Montalmant; Teresa A Milner
Journal:  Exp Neurol       Date:  2005-09-27       Impact factor: 5.330

9.  Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats.

Authors:  Jinsong Zeng; Lisa M Thomson; Sue A Aicher; Gregory W Terman
Journal:  J Neurosci       Date:  2006-11-15       Impact factor: 6.167

10.  Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states.

Authors:  P Honor; P M Menning; S D Rogers; M L Nichols; A I Basbaum; J M Besson; P W Mantyh
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

View more
  6 in total

Review 1.  Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn.

Authors:  Xue Jun Liu; Michael W Salter
Journal:  Eur J Neurosci       Date:  2010-07-11       Impact factor: 3.386

Review 2.  Ionotropic glutamate receptors in spinal nociceptive processing.

Authors:  Max Larsson
Journal:  Mol Neurobiol       Date:  2009-10-31       Impact factor: 5.590

3.  Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons.

Authors:  Tally M Largent-Milnes; Deborah M Hegarty; Sue A Aicher; Michael C Andresen
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

4.  Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray.

Authors:  A R Wilson-Poe; M M Morgan; S A Aicher; D M Hegarty
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

5.  Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors.

Authors:  Anna P Andreou; Philip R Holland; Michele P Lasalandra; Peter J Goadsby
Journal:  Pain       Date:  2015-03       Impact factor: 7.926

6.  Peripheral nerve injury increases glutamate-evoked calcium mobilization in adult spinal cord neurons.

Authors:  Suzanne Doolen; Camille B Blake; Bret N Smith; Bradley K Taylor
Journal:  Mol Pain       Date:  2012-07-28       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.